# Media & Stories Boehringer Ingelheim’s hub for providing you with the latest press releases, news, background stories, and further press material for download. ## Press Releases [European Commission approves JASCAYD®, well-tolerated, novel oral treatment for IPF and PPF](/content/human-health/lung-diseases/pulmonary-fibrosis/european-commission-approves-jascayd-novel-treatment-ipf-ppf "European Commission approves JASCAYD novel treatment IPF PPF"/index.html) July 17, 2026 ### European Commission approves JASCAYD®, well-tolerated, novel oral treatment for IPF and PPF [Read more](/content/human-health/lung-diseases/pulmonary-fibrosis/european-commission-approves-jascayd-novel-treatment-ipf-ppf "Read more about \"European Commission approves JASCAYD®, well-tolerated, novel oral treatment for IPF and PPF\""/index.html) [Boehringer strengthens obesity pipeline as potential first-in-class triple receptor agonist enters Phase II](/content/human-health/crm-health/metabolic-health/obesity-potential-first-class-triple-receptor-agonist-phase-2 "Obesity potential first-in-class triple receptor agonist Phase 2"/index.html) July 16, 2026 ### Boehringer strengthens obesity pipeline as potential first-in-class triple receptor agonist enters Phase II [Read more](/content/human-health/crm-health/metabolic-health/obesity-potential-first-class-triple-receptor-agonist-phase-2 "Read more about \"Boehringer strengthens obesity pipeline as potential first-in-class triple receptor agonist enters Phase II\""/index.html) [Boehringer reports first-half 2026 sales growth, driven by JARDIANCE® and product launches](/content/about-us/who-we-are/boehringer-ingelheim-half-year-results-2026 "Boehringer Ingelheim half-year results 2026"/index.html) July 15, 2026 ### Boehringer reports first-half 2026 sales growth, driven by JARDIANCE® and product launches [Read more](/content/about-us/who-we-are/boehringer-ingelheim-half-year-results-2026 "Read more about \"Boehringer reports first-half 2026 sales growth, driven by JARDIANCE® and product launches\""/index.html) ## Newsbits [Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico](/content/about-us/sustainable-development/boehringer-fund-backs-healthcare-innovators-africa-mexico "boehringer-fund-backs-healthcare-innovators-africa-mexico"/index.html) July 09, 2026 ### Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico [Read more](/content/about-us/sustainable-development/boehringer-fund-backs-healthcare-innovators-africa-mexico "Read more about \"Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico\""/index.html) [Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published](/content/human-health/cancer/lung-cancer/study-results-zongertinib-her2-mutant-advanced-nsclc-published-nejm "Study results zongertinib HER2-mutant advanced NSCLC published NEJM"/index.html) April 16, 2026 ### Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published [Read more](/content/human-health/cancer/lung-cancer/study-results-zongertinib-her2-mutant-advanced-nsclc-published-nejm "Read more about \"Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published\""/index.html) [Three investments mark a strong finish to 2025 for Social Engagement Fund](/content/about-us/sustainable-development/2025-africa-investments-social-engagement-fund "2025 Africa investments Social Engagement Fund"/index.html) March 17, 2026 ### Three investments mark a strong finish to 2025 for Social Engagement Fund [Read more](/content/about-us/sustainable-development/2025-africa-investments-social-engagement-fund "Read more about \"Three investments mark a strong finish to 2025 for Social Engagement Fund\""/index.html) ## Stories [Empowering patients to lead change](/content/human-health/patients/patient-partnership/empowering-patients-advocate-patient-experience-data-ped "Empowering Patients to Advocate with Patient Experience Data (PED/index.html)") Patient Partnership ### Empowering patients to lead change Our commitment to evidence-based patient advocacy with patient experience data (PED) and patient participation in healthcare decision-making. [Read more](/content/human-health/patients/patient-partnership/empowering-patients-advocate-patient-experience-data-ped "Read more about \"Empowering patients to lead change\""/index.html) [Is this the end of the paper leaflets?](/content/human-health/patients/patient-safety/electronic-product-information-end-paper-leaflets "Electronic product information: Is this the end of the paper leaflets?"/index.html) Patient Safety & Pharmacovigilance ### Is this the end of the paper leaflets? Enhancing access to medical information for patients. [Read more](/content/human-health/patients/patient-safety/electronic-product-information-end-paper-leaflets "Read more about \"Is this the end of the paper leaflets?\""/index.html) [Saving lives by breaking silos](/content/human-health/crm-health/metabolic-health/holistic-crm-care-saving-lives-breaking-silos "Holistic CRM care: Saving lives by breaking silos"/index.html) Metabolic Health ### Saving lives by breaking silos A call for integrated care in tackling some of the most devastating conditions, by Shashank Deshpande, Chairman of the Board of Managing Directors [Read more](/content/human-health/crm-health/metabolic-health/holistic-crm-care-saving-lives-breaking-silos "Read more about \"Saving lives by breaking silos\""/index.html) ### Media Contacts [Harro Ten Wolde](mailto:press@boehringer-ingelheim.com) Harro Ten Wolde Head of Global Media Relations E-Mail: [press@boehringer-ingelheim.com](mailto:press@boehringer-ingelheim.com) Phone Number: +49 (6132) 77-181352 [Tereza Urbankova](mailto:press@boehringer-ingelheim.com) Tereza Urbankova Senior Media Relations Manager E-Mail: [press@boehringer-ingelheim.com](mailto:press@boehringer-ingelheim.com) Phone Number: +49 (6132) 77-184817 [Mark Valentiner](mailto:press@boehringer-ingelheim.com) Mark Valentiner Senior Media Relations Manager E-Mail: [press@boehringer-ingelheim.com](mailto:press@boehringer-ingelheim.com) Phone Number: +49 (6132) 77-170136 [Valerie-Chiara Nestle](mailto:press@boehringer-ingelheim.com) Valerie-Chiara Nestle Media Relations Manager E-Mail: [press@boehringer-ingelheim.com](mailto:press@boehringer-ingelheim.com) Phone Number: +49 (7351) 54-175075 [Heidi De Wit-Sommerfeld](mailto:press@boehringer-ingelheim.com) Heidi De Wit-Sommerfeld Head of Animal Health Communications E-Mail: [press@boehringer-ingelheim.com](mailto:press@boehringer-ingelheim.com) Phone Number: +49 (6132) 77-171799 [Liza Konz](mailto:press@boehringer-ingelheim.com) Liza Konz Head of Innovations Unit Communications E-Mail: [press@boehringer-ingelheim.com](/content/press@boehringer-ingelheim.com) Phone Number: +49 (6132) 77-174201 ## Current Events ### Please check back later! There are no upcoming events in the near future. ## Past Events [Annual Press Conference 2026](/content/about-us/annual-press-conference-2026 "Annual Press Conference 2026"/index.html) About us ### Annual Press Conference 2026 - March 25, 2026 - 10:30 - Ingelheim, Germany and online [Annual Press Conference 2025](/content/about-us/annual-press-conference-2025 "Annual Press Conference 2025"/index.html) About us ### Annual Press Conference 2025 - April 2, 2025 - 10:30 - Ingelheim, Germany and online [Save the Date! Transforming Science Day: 2025](/content/science-innovation/human-health-innovation/heidelberg-transforming-science-day-2025 "Heidelberg Transforming Science Day 2025"/index.html) Human Health Innovation ### Save the Date! Transforming Science Day: 2025 - February 25, 2025 - 1:00 - 6:00 p.m. CET - Heidelberg, Germany ### References